The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Shionogi competitive analysis

Loading summary...

Latest patents of Shionogi opposed by its competitors

Explore Shionogi's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3045206
Feb 15, 2023Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
EP3616720
Feb 17, 2021Pharmaceutical Composition For Cancer Treatment10
EP2772480
Dec 9, 2020Hiv Replication Inhibitor1
EP3431105
Jan 1, 2020Medicinal Composition For Treating Cancer5
EP3284520
Jun 5, 2019Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
EP2266958
Mar 15, 2017Antiviral Agent1

Latest PTAB cases involving Shionogi

Discover the latest PTAB cases involving Shionogi, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Shionogi with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SHIONOGI - 19 - -
GEVERS & ORES7 - - -
GLAXOSMITHKLINE29112812
J A KEMP40 - - -